These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 19087082
1. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. Signorelli M, Caspani G, Bonazzi C, Chiappa V, Perego P, Mangioni C. BJOG; 2009 Jan; 116(1):114-8. PubMed ID: 19087082 [Abstract] [Full Text] [Related]
2. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women]. Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ. Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458 [Abstract] [Full Text] [Related]
7. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T. J Clin Oncol; 2007 Jul 01; 25(19):2798-803. PubMed ID: 17602085 [Abstract] [Full Text] [Related]
8. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Yamazawa K, Hirai M, Fujito A, Nishi H, Terauchi F, Ishikura H, Shozu M, Isaka K. Hum Reprod; 2007 Jul 01; 22(7):1953-8. PubMed ID: 17449880 [Abstract] [Full Text] [Related]
10. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium. Yu M, Yang JX, Wu M, Lang JH, Huo Z, Shen K. Fertil Steril; 2009 Dec 01; 92(6):2122-4. PubMed ID: 19591991 [Abstract] [Full Text] [Related]
11. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Wheeler DT, Bristow RE, Kurman RJ. Am J Surg Pathol; 2007 Jul 01; 31(7):988-98. PubMed ID: 17592264 [Abstract] [Full Text] [Related]
13. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma. Kudesia R, Singer T, Caputo TA, Holcomb KM, Kligman I, Rosenwaks Z, Gupta D. Am J Obstet Gynecol; 2014 Mar 01; 210(3):255.e1-4. PubMed ID: 24211482 [Abstract] [Full Text] [Related]
15. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option. Gadducci A, Spirito N, Baroni E, Tana R, Genazzani AR. Gynecol Endocrinol; 2009 Oct 01; 25(10):683-91. PubMed ID: 19562604 [Abstract] [Full Text] [Related]
17. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT. Arch Gynecol Obstet; 2012 Feb 01; 285(2):473-8. PubMed ID: 21706284 [Abstract] [Full Text] [Related]